![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 13, 11513-11520, March 29, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
§, and
From the
Department of Molecular and Cellular
Biochemistry and Center for Structural Biology and the
§ Department of Chemistry, The University of Kentucky,
Lexington, Kentucky 40536
Received for publication, November 28, 2001, and in revised form, January 22, 2002
| |
ABSTRACT |
|---|
|
|
|---|
The crystal structure of the nitroreductase
enzyme from Enterobacter cloacae has been determined for
the oxidized form in separate complexes with benzoate and acetate
inhibitors and for the two-electron reduced form. Nitroreductase is a
member of a group of enzymes that reduce a broad range of nitroaromatic
compounds and has potential uses in chemotherapy and bioremediation.
The monomers of the nitroreductase dimer adopt an Nitroaromatic compounds are pervasive pollutants whose toxicity is
generally the result of their enzymatic reduction to more reactive
species (1-3). There is considerable interest in the flavin-containing
nitroreductases that catalyze the reductive activation of nitrated
aromatics, because of their central role in mediating nitroaromatic
toxicity (4-9), their potential use in bioremediation (1-3, 10), and
their utility in activating prodrugs in directed anticancer therapies
(11, 12).
The nitroreductase from Enterobacter cloacae
(NR)1 catalyzes two-electron
reduction of a variety of nitrated aromatics as well as quinones and
flavins (13-16). Indeed, this enzyme was first isolated from bacteria
growing in a weapons storage dump, and can reduce trinitrotoluene (80).
NR reduces nitrobenzene to the corresponding hydroxylamine and derives
reducing equivalents from reduced nicotinamide adenine dinucleotide
(NADH), reduced nicotinamide adenine dinucleotide phosphate (NADPH), or
other nicotinamides (15) by means of a flavin mononucleotide cofactor (FMN) (13, 14).
NR follows ping-pong bi-bi kinetics, and its FMN groups cycle between
the oxidized neutral and reduced anionic states with an
Eox/hq of Several other FMN-containing oxidoreductases have been identified that
have similar broad substrate specificity ranges and also do not
stabilize the semiquinone state of the bound flavin. They are
homodimers that share a similar fold and key amino acids, although the
amino acid identities conserved over the whole group are few (17). The
minor O2-insensitive nitroreductase of Escherichia coli (NTR or NfsB), shares 88% sequence identity with NR (18). The major NAD(P)H:FMN oxidoreductase of Vibrio fischeri
(FRase I) shares only 33% sequence identity (17, 19) whereas NADH oxidase from Thermus thermophilus (NOX) is even more
remotely related (20, 21). Additional homologues include the major O2-insensitive nitroreductase of Escherichia coli
(NfsA) (22) and NADPH:flavin oxidoreductase of Vibrio
harveyi (FRP) (23). Crystal structures have been deposited and/or
published for several members of this family in the oxidized state, and
all show an FMN bound at the interface between monomers in each of two
symmetry-related but independent active sites
(24-29).2
We have determined crystal structures of oxidized NR in complex with
two different inhibitors of the first half reaction as well as the
crystal structure of the reduced
enzyme.3 This work represents
the most extensive comparison of states yet published for an NR
homologue and includes the first crystal structure of one of these
enzymes in the reduced state. Details of the flavin conformation and
inhibitor binding interactions provide novel insights into the bases
for the oxygen insensitivity and substrate specificity range of this
important family of enzymes.
Protein Crystallization--
E. cloacae
nitroreductase was overexpressed in Escherichia coli and
purified according to published methods (30). The purified enzyme was
stored at a concentration of 4.75 mg/ml in 50 mM
KH2PO4 (pH 7), 0.02% (w/v) NaN3.
The protein buffer was exchanged with 10 mM HEPES (pH 7)
and 50 mM KCl prior to crystallization.
Crystals of oxidized NR were grown by hanging-drop vapor diffusion at
4 °C against well solution containing 100 mM homopipes (pH 4.8), 25 mM acetate, and 15% PEG-4000. They grew to
full size (0.5 × 0.5 × 0.1 mm) within 30 days. Prior to
data collection, crystals were dialyzed against cryoprotectant solution
containing 100 mM HEPES (pH 4.8), 25 mM sodium
acetate, 25% PEG-4000, and 18% glycerol for 16 h. The crystals
were mounted in nylon loops and flash cooled by plunging into liquid
nitrogen (31).
Formation of the Benzoate Complex--
Oxidized NR crystals were
dialyzed against cryoprotectant solution containing 100 mM
HEPES (pH 4.8), 600 mM sodium benzoate, 25% PEG-4000, and
18% glycerol for 20 h prior to flash cooling.
Chemical Reduction of Oxidized Crystals--
A fresh solution of
sodium dithionite was added to cryoprotectant, and 25 µl of the
resulting solution was gently mixed with oxidized NR crystals in 25 µl of cryoprotectant. After ~10 min, 25 µl of cryoprotectant
buffer was removed and replaced with 25 µl of cryoprotectant buffer
containing dithionite. This procedure was repeated two more times. The
crystals lost their deep yellow color over the course of the treatment.
They were then immediately flash cooled and stored in liquid nitrogen
prior to data collection.
Data Collection and Structure Determination--
Crystals were
held at 115 K for data collection on a CuK
Initial structures were determined by molecular replacement using the
CNS software package (34) and the coordinate set of unliganded
nitroreductase2 as a search object. Geometry restraint
files for acetate and benzoate were taken from the HIC-UP site (35).
Initial restraint files for FMN were also taken from the HIC-UP site
and modified to reflect theoretical values for oxidized and reduced
flavin (36). Individual weighting values for the FMN geometry
parameters were adjusted to give stable refinement while still allowing
the flavin to adopt the correct conformation (as judged by omit density and tests with low geometry weights and noncrystallographic symmetry restraints on the FMN groups to stabilize refinement). Initial manual
rebuilding was followed by simulated annealing refinement in CNS and
subsequent cycles of manual rebuilding (37), addition of ordered
solvent, and energy minimization. The resolution and quality of the
data were sufficient for refinement without applying noncrystallographic symmetry restraints. Final refinement parameters are given in Table II.
Flavin Mononucleotide Binding and Geometry in the Oxidized
State--
NR (13, 14) and homologous enzymes (17, 18, 21, 38, 39) are
dimers of 24-kDa subunits that share a characteristic
Affinity for the FMN cofactor is high (10 nM), and within
this structural family, binding typically involves extensive
interactions with the protein, some of which are conserved or similar
across the group. The polar groups in the isoalloxazine ring of FMN
typically participate in a number of hydrogen bond interactions with
protein, and seven hydrogen bonds with the flavin are present in the NR crystal structure. One group of contacts involves the N1, O4, and N3
positions of the ring system, including donation of a hydrogen bond by
the backbone amide of Glu-165 to N5, which is thought to be the
site of hydride transfer (40). This set of interactions is remarkably
well conserved across the entire group of homologues, although the
identities of some residues vary. One interacting residue, Gly-166 in
NR, is absolutely conserved within the group. Main-chain torsion angles
for this residue are either near the
The other group of contacts with the isoalloxazine ring involves the O2
and in some cases N1 atoms, which largely interact with basic residues.
In NR and NTR, for example, there are two strong interactions between
O2 of the pyrimidine ring and lysines 14 and 74. Unlike the first set
of contacts, however, these interactions vary substantially across the
group of related enzymes. This variation within the second group of
interactions is particularly interesting, because the anionic forms of
both the one- and two-electron reduced flavins develop resonance
stabilized negative charge at the N1-C2=O2 locus. Positive
electrostatic potential from the protein near this region is a common
feature of flavoenzymes, and the degree of positive charge is thought
to be a strong factor in determining the redox potential of the system
(40, 41). Variations in the exact nature of the contacts within the
related group may then modulate the redox characteristics of the enzymes.
In each of the NR homologues, the carbonyl oxygen from a residue
located on the si side of the flavin interacts with the
The extensive interactions with the protein have a substantial effect
on the conformation of the flavin. Both structural (43-49) and
computational studies (36, 50-53) suggest that the free isoalloxazine ring system is close to planar in the oxidized state. In contrast, the
flavins in the oxidized NR structures are curved along their lengths
(Fig. 3). This distortion of the isoalloxazine has been termed
butterfly bending to indicate a rigid motion of the two end rings about
the N5-N10 axis. Both oxidized structures have the same overall bend
of ~16°, with an r.m.s. difference in atomic positions of only 0.03 Å. Although there have been other flavoproteins reported with similar
or even more extreme butterfly bends, they are rare, probably
comprising 10% or less of the reported structures (54).
Crystallographic thermal factors indicate low mobility of the flavin,
with an average on all atoms of 12.5 Å2 for the oxidized
acetate complex and 11.4 Å2 for the oxidized benzoate
complex. The flavin is rigidly fixed by interactions with the protein
and is not disturbed by binding different ligands over the
re face.
It is likely that the geometry of the binding site plays a role in
inducing the bent flavin conformation. The dimethylbenzene ring and a
portion of the central ring are held tightly by structural elements on
both faces. Hydrogen bonding groups interacting with the pyrimidine end
of the isoalloxazine arise largely from the si side of the
flavin, the same direction as the bend. On binding, then, the
interactions with the pyrimidine ring are optimized at the cost of
distorting the flavin. Bending of the flavin cofactor has also been
attributed to steric aspects of the binding site in pyruvate oxidase
(55), NADH oxidase (24), and in the reduced form of thioredoxin
reductase (54).
In addition, specific features of the protein-flavin interaction in NR
may affect flavin conformation. Among the NR homologues, the
interactions that stand out are: 1) the presence of an electron rich
group (main-chain carbonyl oxygen in NR and its homologues) interacting
with the Inhibitor Binding--
In earlier work (15), we demonstrated that
small negatively charged organic molecules such as acetate and benzoate
are inhibitors of nitroreductase. They act competitively with substrate
(NAD(P)H) for the first half reaction, flavin reduction, and
uncompetitively in the second half reaction, reduction of the
nitroaromatic. The binding of these inhibitors is relatively weak with
overall Ki values of 0.1 mM for benzoate
and 9 mM for acetate, for example (15).
In the two oxidized NR crystal structures, both acetate and benzoate
bind over the pyrimidine and central rings of the isoalloxazine system
in partially overlapping sites (Fig. 4).
The central carbon of the acetate is located above a point midway
between flavin atoms C4a and C10a, so that the bulk of the molecule
lies over the central ring. The carboxylate group of benzoate is in a
similar position, but shifted over toward the pyrimidine ring of the
flavin. The benzene ring is not stacked over the isoalloxazine
Both acetate and benzoate are positioned ~3.6 Å above the flavin,
making van der Waals contacts with a number of ring atoms. The acetate
methyl group also contacts atoms in protein residues, in particular
O
While preparation of this paper was in progress, the structure of NTR
with bound nicotinic acid, a first half reaction substrate analogue,
was published (29). Nicotinic acid binds in the same position and
orientation as the benzoate in the NR complex. Structures of
flavoenzymes with pyridine nucleotide bound in positions consistent with hydride transfer (57-59), also show the nicotinamide group stacking over either the re or si face of the
isoalloxazine system. In NR then the organic acid inhibitors overlap
the reducing substrate binding site, consistent with their competitive
inhibition of the first half reaction.
Substrates for the second half reaction, the oxidizing substrates,
probably also bind over the re face of the reduced flavin to
effect hydride transfer. This location of the nitroaromatic binding
site is consistent with the ping-pong kinetic mechanism of NR (15).
Also, mutation of the phenylalanine in NfsA equivalent to Phe-124,
which interacts with bound organic acids, affects nitroaromatic
substrate specificity (60). NR is capable of reducing a variety of
nitroaromatics and isoalloxazine derivatives (15), and other members of
this structural group also show broad substrate specificity (18, 20,
22, 61). If the organic acid inhibitors bind at the same site as
oxidizing substrates, then the crystal structures with the inhibitors
suggest a mechanism for accommodating substrates of different size. The
plasticity of helix H6, demonstrated by its response to the two
different organic acid inhibitors, creates a variable volume cavity
capable of conforming to different bound substrates. The helices
equivalent to H6 in crystal structures of other members of the group
also show elevated thermal factors and variability in position
indicative of inherent plasticity (24-29). These enzymes probably use
a similar mechanism for adapting to different substrates. Depending on
the type and size of oxidizing substrate, other nearby aromatic
residues (Tyr-68, Phe-70, Tyr-123) may also participate in the binding
interaction. Interestingly, the identity of these residues varies among
the related flavoenzymes, suggesting that they may play a role in
determining substrate preferences (15, 18, 20, 22, 61).
The Reduced Form of the Enzyme--
Although a number of crystal
structures have been determined for members of the nitroreductase
group, no structures have been reported for reduced enzymes. Upon
reduction of NR, there is an increase in the butterfly bend angle of
the isoalloxazine ring system (Fig.
6a). Although both oxidized
forms have a bend angle of ~16°, the bend in the si
direction of the reduced flavin increases to 25°. This extreme
conformation places it among the three largest flavin bend angles found
in a recent survey of unique flavoprotein structures in the Protein
Data Bank (54). The change in bend angle in NR occurs primarily as a
rigid motion about the N5-N10 axis, so that each half of the ring
system independently superimposes well (r.m.s. of ~0.03 Å) on the
oxidized form, but the angle between the two halves has changed. There
is considerable disagreement about the equilibrium conformation of the
fully reduced anionic flavin (36, 48, 50, 52, 53, 62-64), the form
found in reduced NR. Recent theoretical work, however, has predicted a large butterfly bend of 27-29° for this form of free flavin (52, 63,
64). The observed bend of 25° in reduced NR is close to these values
suggesting that in the reduced state the protein may not greatly
influence the equilibrium conformation of the isoalloxazine system.
Residues that interact with the ring system accommodate the increased
bend of the reduced flavin by a largely rigid movement of nearby
structural elements. The largest shifts of the isoalloxazine ring
substituents are ~0.3 Å when oxidized, and reduced flavins are
aligned on the center ring (C4a, C5a, C9a, C10a), and the shifts in the
nearby protein elements are comparable. Polar groups that interact with
the pyrimidine ring and N5 include Lys-14 from the open coil between H1
and H2, and Asn-71 and Lys-74 from H4. On the dimethylbenzene side,
Ile-164 from the open coil between S3 and H8, Tyr-144, and Leu-145 from
H7 also follow the bend of the flavin. Ser-39 and Ser-40 from the other
monomer, which sit over the central ring, move very little upon
reduction of the flavin. Proline 163 on the other side of the central
ring shifts (by 0.15 Å) parallel to the plane of the ring, presumably
as a consequence of the shifts at positions 164 and 165. Any changes in
the central ring structure or electronics upon flavin reduction therefore do not result in large rearrangements of protein groups above
and below the ring.
The central flavin ring puckers into a boat conformation upon
reduction, with N5 moving up and out of the plane formed by the carbons
(Fig. 6b). N10 also shifts more out of the plane, but this
movement is small relative to the movement of N5. These changes reflect
a loss of planarity at the central ring carbons, particularly C4a and
C5a, that accompanies the increase in butterfly bending associated with
reduction. The amide NH group of Glu-165, which hydrogen bonds with N5
in the oxidized flavin, still participates in this interaction in the
reduced form. Glu-165 does not follow the shift in N5, however, and the
distance between the two nitrogens increases to 3.22 ± 0.03 Å (average for four monomers in the crystal asymmetric unit) from values
of 3.11 ± 0.03 Å and 3.13 ± 0.03 Å for the oxidized
acetate and oxidized benzoate complex structures, respectively.
With only this modest accommodation of hydride transfer to N5 in
reduced NR, the amide proton of Glu-165 remains in close proximity to
the ring nitrogen, well stabilized by a network of interactions that
prevent this region of the protein from rearranging. A consequence of
this steric restriction is that hydride transfer must occur in the
axial position at N5, which adopts sp3 hybridization.
Although the overall effect of hydrogen bond donation may be to
disfavor protonation at N5 (39, 60, 62, 84-86), participation of the
N5 lone pair in the hydrogen bond in the oxidized state should somewhat
deshield the axial position, making N5 more susceptible to nucleophilic
attack by a reducing substrate positioned above the re face
of the flavin. The axial position would also be the correct orientation
for direct hydride transfer to an oxidizing substrate located in a
similar position. No difference density is present for the hydrogen on
N5, but hydrogen density is not expected in a 1.9-Å structure.
Finally, although crystals of NR were grown and reduced in the presence
of the same acetate concentration as the acetate complex crystals, the
acetate bound over the re side of the flavin is displaced
and two ordered solvent molecules now occupy a portion of that volume
(Fig. 7). One water molecule is located
roughly above N5 near the position of the ligand methyl group in the
acetate complex. The other water is located over N10 and C10a, largely overlapping the position of one of the ligand carboxylate oxygens in
the acetate complex. The two new solvent molecules in the reduced structure participate in a hydrogen bond network that includes several
interactions with nearby protein residues and the flavin (Fig. 7). The
solvent molecule above N5 is positioned to make a hydrogen bond
interaction via the axial hydrogen at N5, further supporting this
position for hydride transfer. This solvent in turn is hydrogen-bonded
to the second new water and to the O
There appear to be two factors that contribute to the loss of acetate
binding in the reduced enzyme. The axial hydrogen at N5 could clash
with the methyl group of bound acetate, reducing affinity. Also,
electronic restructuring of the reduced flavin may help to change the
binding affinity for organic acids. Koder et al. (15)
provide evidence for the anionic hydroquinone form of the flavin in
reduced NR, and as noted above, much of the negative electrostatic
potential in the anionic form would be predicted to reside in the
N1-C2=O2 locus. Because the negatively charged group of these
inhibitors is positioned over this locus when bound, it is probable
that electrostatic repulsion decreases binding affinity.
NR Redox Properties and Flavin Geometry--
Many aspects of the
interaction between flavoproteins and their prosthetic groups are
thought to influence the redox properties of the system. In NR, effects
that favor reduction must balance those that favor the oxidized form of
the flavin, because the Eox/hq of
The hallmark of NR redox chemistry is its inability to stabilize the
one electron reduced semiquinone form of the flavin (15, 81). Thus,
reduction by the second electron is thermodynamically more favorable
than the first one electron reduction, which corresponds to a large
positive difference between the second and first one-electron redox
midpoint potentials, Esq/hq and
Eox/sq, of at least +381 mV. The lack of a one
electron-reduced state is relatively rare among flavoenzymes, which
generally act to stabilize the semiquinone (68, 69). The broad
substrate specificity of NR may allow it to fully reduce a number of
cellular compounds that might otherwise contribute to oxidative stress
via one electron reduction (70). Indeed, the related NfsA has recently
been demonstrated (71) to be part of the soxRS regulon in E. coli, which is induced by redox cycling agents.
The hydrogen bond donated to N5 of the flavin may play a role in the
lack of semiquinone stabilization. Donation of a hydrogen bond by the
protein may disfavor reduction by increasing the cost of protonating
N5. In flavodoxin from Clostridium beijerinckii, the
interaction of a hydrogen bond acceptor with N5 appears to both
increase Eox/sq and decrease
Esq/hq to account in part for the strongly
stabilized semiquinone in this enzyme (72). Donating a hydrogen bond
rather than accepting one might have the opposite effect in NR. It is
not apparent, however, why this effect should favor the hydroquinone
form over the neutral semiquinone, because both are protonated at N5
and probably carry similar atomic charges at that position (63, 73).
Also, it does not explain the absence of the anionic semiquinone, which
is not protonated at N5. Old yellow enzyme makes a similar hydrogen
bond to N5 of its prosthetic group (74) and yet stabilizes the anionic
semiquinone state at the level of 10-20% (75, 76). This enzyme, in
fact, makes contacts with its isoalloxazine system that are very
similar to those we observe in NR (74). Unlike NR, however, the flavin in old yellow enzyme has only a small butterfly bend in the oxidized state, and this difference may in part explain the different redox properties of the two enzymes. Because all forms of the free
semiquinone are believed to be nearly planar (52, 53, 63, 77), the highly bent conformation of the flavin in NR may play a role in its
inability to stabilize the one electron reduced form of the prosthetic
group. For free flavin, a bend angle of 16°, the conformation in
oxidized NR, would destabilize either the neutral or anionic semiquinone forms by ~8 kcal/mol (63), a change in midpoint potential
of ~350 mV. This substantial energetic cost may counterbalance the
normal tendency toward semiquinone stabilization in the protein environment. The extent of this effect depends on the exact nature of
the interaction, however, and a more detailed evaluation of the
possible mechanisms of redox tuning in NR raised by the crystal structures reported here must await additional theoretical and experimental studies.
+
fold and
together bind two flavin mononucleotide prosthetic groups at the dimer interface. In the oxidized enzyme, the flavin ring system adopts a
strongly bent (16°) conformation, and the bend increases (25°) in
the reduced form of the enzyme, roughly the conformation predicted for
reduced flavin free in solution. Because free oxidized flavin is
planar, the induced bend in the oxidized enzyme may favor reduction, and it may also account for the characteristic inability of the enzyme
to stabilize the one electron-reduced semiquinone flavin, which is also
planar. Both inhibitors bind over the pyrimidine and central rings of
the flavin in partially overlapping sites. Comparison of the two
inhibitor complexes shows that a portion of helix H6 can flex to
accommodate the differently sized inhibitors suggesting a
mechanism for accommodating varied substrates.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
190 mV, near that of free FMN (81).
Single-electron redox chemistry and associated formation of the
semiquinone are not stabilized. This results in NR's activity being
"oxygen-insensitive," in that the enzyme does not readily transfer
one electron to molecular oxygen to form the superoxide radical (13,
15).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
source with an R-AXIS
IV++ image plate detector. Data were reduced with the HKL
(32) and CCP4 packages (33). The crystal and data parameters are given in Table I. In all crystals there
are four monomers, or two dimers, in the asymmetric unit.
Summary of crystallographic data
Summary of refinement
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
+
fold
(Fig. 1). A central sheet consists of
four antiparallel strands, with a fifth, parallel strand arising from
the C terminus of the other dimer subunit. Surrounding the sheet are
two large helices on one side, three smaller helices on the other, and
two helices that pack against one end of the sheet. Several small helices or helical turns are also present. The FMN prosthetic groups
bind in deep pockets at the dimer interface and interact with elements
from both monomers (see Fig. 2 for FMN
structure and numbering). In NR, each flavin group packs up against one end (S3) of the central sheet and is surrounded by helices H4 and H7.
Helix H6 and the loop between H2 and S1 (particularly residues 36-43)
from the other subunit form a cap over the cofactor binding site. H7
from that monomer also contributes to the pocket.

View larger version (30K):
[in a new window]
Fig. 1.
Overview of the nitroreductase fold.
a, ribbons diagram of the nitroreductase dimer
showing the location of the flavin mononucleotide prosthetic groups
(yellow bonds) at the dimer interface. The bound
acetate molecule is shown with red bonds.
b, topology of nitroreductase. Panel a was
prepared with the program RIBBONS (78).

View larger version (12K):
[in a new window]
Fig. 2.
Chemical structure and atom numbering of the
flavin mononucleotide prosthetic group of nitroreductase.
a, oxidized flavin; b, fully reduced anionic form
of the flavin. In both panels, the flavin is oriented as if viewing the
re face. The other orientation is referred to as the
si face.
-strand region of the
Ramachandran plot (NR, NTR, FRase I, and NOX) or in the helical region
(FRP and NfsA), both allowed positions for residues with side chains.
Glycine is not, therefore, required at this position because of its
greater backbone flexibility. Instead it may be conserved, because any
side-chain atoms would intrude on space over the flavin reserved for
substrate binding.
system at the central ring (Fig. 3). The
carbonyl oxygen is contributed by a proline residue (Pro-163) in NR. It
is positioned about 2.8 Å from the plane of the central ring and
almost directly below its center point, where the protein backbone runs
across the short axis of the flavin. The rigid proline residue in NR is
not required to place the carbonyl group in the observed orientation.
Although both NTR and NOX also have prolines at this position, FRase I has a threonine (Thr-163), and NfsA and FRP both have tyrosines. As
noted by others (42), this interaction of an electronegative group with
the central region of the isoalloxazine ring is found in a number of
flavin-containing proteins.

View larger version (54K):
[in a new window]
Fig. 3.
Conformation and electron density for the FMN
prosthetic group of nitroreductase. Edge-on view of the flavin
showing the electron donor-
interaction with the carbonyl oxygen of
Pro-163. 2Fo
Fc density was
averaged over the four independent molecules in the crystal asymmetric
unit and displayed at two times the r.m.s. deviation of the map. The
PDBVIEWER software (79) was used to create the figures.
system of the isoalloxazine at or near the central ring,
2) a hydrogen bond donor (main-chain amide in NR and homologues)
interacting with N5 of the flavin, 3) the presence of positively
charged residues near the N1-C2=O2 locus, and 4) the absence of
parallel
-
stacking of aromatic side chains with the flavin. To
assess the significance of these interactions, we examined 54 flavoproteins in a unique data set identified by Lennon et
al. (54) for the presence of each of the four interactions and
grouped the data into three bend angle classes: 0-5°, 5-10°, and
>10°. Only parallel stacking of the flavin with an aromatic group
from the protein was clearly correlated with bend angle, being absent
in all twelve structures in the highest bend angle group. All of the
surveyed aromatic interactions involve stacking, at least in part, with
the central ring of the isoalloxazine. Because this ring becomes
significantly nonplanar and the
system weakens in a highly bent
flavin, the presence of a stacking interaction would tend to inhibit
butterfly bending. Two of the other features, basic amino acid residues
interacting with N1-C2=O2 and a hydrogen bond donated to N5, are more
prevalent in the large bend angle group, but the small size of the
sample limits the significance of this observation. The prevalence of
H-bond donor interactions is particularly attractive, because they
might directly affect the resonance characteristics of the central
ring, which accounts for a large portion of the distortion associated
with butterfly bending.
system. Rather it extends out over O4 of the flavin and the gap between the pyrimidine and central rings. Both inhibitors hydrogen bond to the
O2' oxygen of the ribose moiety, and the same carboxylate oxygen of
each inhibitor interacts with the main-chain NH of Thr-40, which is
located in the loop between H2 and S1 that helps form the flavin
binding site. The other carboxylate oxygen of acetate interacts with
two water molecules, one of which also hydrogen bonds to O2' of the
ribose. The corresponding benzoate oxygen is shifted toward N1 of the
flavin, altering the water structure relative to the acetate complex.
It interacts with only a single water molecule, which is not equivalent
to either of the acetate complex solvent molecules. In general, the
presence of a negatively charged group seems to define this class of NR
inhibitors (15). Because both acetate and benzoate bind with their
carboxylate groups near lysines 14 and 74, electrostatic interaction
with these residues may be a principle reason for the binding of these inhibitors.

View larger version (40K):
[in a new window]
Fig. 4.
Inhibitor binding to nitroreductase.
a, binding of acetate over the isoalloxazine ring system;
b, binding of benzoate over the isoalloxazine ring system.
Averaged omit density for both inhibitors is contoured at three times
the r.m.s. deviation of the map.
of Ser-40, C
of Thr-41, and the side-chain atoms of Phe-124,
and these interactions presumably contribute to binding affinity. The
protein residues and flavin define a cavity that is only large enough
to accept the acetate methyl group. Binding of benzoate, therefore,
requires rearrangement to accommodate this much larger inhibitor. The
cavity is enlarged almost exclusively by side-chain and main-chain
shifts in helix H6 (Fig. 5), the large
helix that is positioned over the re face of the
isoalloxazine ring. The movement occurs primarily at two residues,
Phe-124, which directly interacts with the bound inhibitor, and
Tyr-123, which contacts the other side of the Phe-124 side chain. For
both residues, the C
atoms shift about 0.6 Å between the two
complex structures. Changes in the main-chain torsion angles and chi1 side-chain torsion angles amplify this movement, so that Phe-124 shifts
by 2.5 Å at its distal ring carbon. The tighter binding of benzoate
over acetate may be due in large part to the favorable interaction (56)
between its aromatic ring and the phenyl group of Phe-124.

View larger version (30K):
[in a new window]
Fig. 5.
Shifts in helix H6 to accommodate the larger
benzoate inhibitor. H6 bonds are blue in the acetate
structure and red in the benzoate complex. The density and
structure of the bound benzoate are shown.

View larger version (18K):
[in a new window]
Fig. 6.
a, Edge-on view of
superimposed FMN groups from the three nitroreductase structures. The
oxidized acetate and benzoate complexes are shown in blue
and yellow, respectively. The reduced structure is shown in
red. b, detail showing the change in N5 position
upon reduction.
of Ser-40. The second water
interacts with the amide group of Thr-41 and O2' of the FMN ribose.

View larger version (24K):
[in a new window]
Fig. 7.
Electron density on the re
side of the reduced flavin. This omit density was averaged
over the four unique molecules in the asymmetric unit and contoured at
three times the r.m.s. deviation of the map.
190 mV is
little different from the
208 mV Eox/hq of
free flavin (81). The most striking feature of NR is the bent flavin
conformation in both oxidation states. Some time ago, Massey and
Hemmerich (65), proposed that the conformation adopted by the flavin
upon binding to the apoprotein may affect the redox potential of the
prosthetic group. Although there has been some controversy over the
importance of this effect (54), recent work (54, 63, 64, 66, 67)
suggests conformational changes may play a role in determining the
redox properties of the protein-flavin system. In oxidized NR, the
isoalloxazine ring system is bound in a conformation that is
energetically unfavorable in the oxidized free flavin, and this imposed
bend may therefore favor reduction. The energetic cost of bending the
ring system in free flavin has been variously estimated, but
often-quoted studies (36, 63) indicate a value in the range of 6 kcal/mol for a bend equal to the oxidized NR flavin (16°). If an
equal cost is incurred in the protein environment, it would translate
to an increase of +130 mV in the two electron reduction potential, a
substantial effect.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Joseph Walsh for helpful discussions and Christina Hines for careful reading of the manuscript.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1KQC, 1KQB, 1KQD) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶ Present address: The Johnson Foundation, Dept. of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.
To whom correspondence should be addressed: Dept. of Molecular
and Cellular Biochemistry, The University of Kentucky, 800 Rose St.,
Lexington, KY 40536. Tel.: 859-257-5205; Fax: 859-323-1037; E-mail:
rodgers@focus.gws.uky.edu.
Published, JBC Papers in Press, January 22, 2002, DOI 10.1074/jbc.M111334200
2 PDB entry 1NEC; H. J. Hecht, C. Bryant, H. Erdmann, H. Pelletier, and R. Sawaya, unpublished data.
3 Atomic coordinates and structure factors have been deposited with the RCSB Protein Data Bank accession numbers: 1KQC (NR-acetate complex), 1KQB (NR-benzoate complex), 1KQD (reduced NR).
| |
ABBREVIATIONS |
|---|
The abbreviations used are: NR, nitroreductase from E. cloacae; NfsA, major oxygen-insensitive NADPH-dependent nitroreductase of E. coli; NTR, minor oxygen-insensitive NAD(P)H-dependent nitroreductase of E. coli; FRase I, major NAD(P)H:FMN oxidoreductase of V. fischeri; NOX, NADH oxidase of T. thermophilus; FRP, NADPH-dependent flavin reductase of V. harveyi; Eox/hq, flavin two-electron reduction midpoint potential relative to the normal hydrogen electrode; Eox/sq, midpoint potential for the oxidized and one-electron reduced pair, Esq/hq, midpoint potential for the one- and two-electron reduced pair; PEG, polyethylene glycol; r.m.s.d., root mean square deviation.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Spain, J. C.
(1995)
Annu. Rev. Microbiol.
49,
523-555[CrossRef][Medline]
[Order article via Infotrieve] |
| 2. |
Esteve-Nunez, A.,
Caballero, A.,
and Ramos, J. L.
(2001)
Microbiol. Mol. Biol. Rev.
65,
335-352 |
| 3. |
Rodgers, J. D.,
and Bunce, N. J.
(2001)
Water Res.
35,
2101-2111[Medline]
[Order article via Infotrieve] |
| 4. |
McCalla, D. R.,
Reuvers, A.,
and Kaiser, C.
(1971)
Biochem. Pharmacol.
20,
3532-3537[CrossRef][Medline]
[Order article via Infotrieve] |
| 5. |
Tokiwa, H.,
and Ohnishi, Y.
(1986)
Crit. Rev. Toxicol.
17,
23-60[Medline]
[Order article via Infotrieve] |
| 6. |
Rickert, D. E.
(1987)
Drug. Metab. Rev.
18,
23-53[Medline]
[Order article via Infotrieve] |
| 7. |
Chung, K. T.,
Murdock, C. A.,
Zhou, Y.,
Stevens, S. E., Jr., Li, Y. S.,
Wei, C. I.,
Fernado, S. Y.,
and Chou, M. W.
(1996)
Environ. Mol. Mutagen.
27,
67-74[CrossRef][Medline]
[Order article via Infotrieve] |
| 8. |
Sera, N.,
Fukuhara, N.,
Miyata, N.,
and Tokiwa, H.
(1996)
Mutat. Res.
349,
137-144[Medline]
[Order article via Infotrieve] |
| 9. |
Purohit, V.,
and Basu, A. K.
(2000)
Chem. Res. Toxicol.
13,
673-692[CrossRef][Medline]
[Order article via Infotrieve] |
| 10. |
Nishino, S. F.,
and Spain, J. C.
(1993)
Appl. Environ. Microbiol.
59,
2520-2525 |
| 11. |
Knox, R. J.,
Friedlos, F.,
and Borland, M. P.
(1993)
Cancer Metastasis Rev.
12,
195-212[CrossRef][Medline]
[Order article via Infotrieve] |
| 12. |
Niculescu-Duvaz, I.,
Friedlos, F.,
Niculescu-Duvaz, D.,
Davies, L.,
and Springer, C. J.
(1999)
Anticancer Drug Des.
14,
517-538[Medline]
[Order article via Infotrieve] |
| 13. |
Bryant, C.,
and DeLuca, M.
(1991)
J. Biol. Chem.
266,
4119-4125 |
| 14. |
Bryant, C.,
Hubbard, L.,
and McElroy, W. D.
(1991)
J. Biol. Chem.
266,
4126-4130 |
| 15. |
Koder, R. L.,
and Miller, A.-F.
(1998)
Biochim. Biophys. Acta
1387,
395-405[CrossRef][Medline]
[Order article via Infotrieve] |
| 16. |
Rafii, F.,
and Hansen, E. B.
(1998)
Antimicrob. Agents Chemother.
42,
1121-1126 |
| 17. |
Zenno, S.,
Saigo, K.,
Kanoh, H.,
and Inouye, S.
(1994)
J. Bacteriol.
176,
3536-3543 |
| 18. |
Zenno, S.,
Koike, M.,
Tanokura, M.,
and Saigo, K.
(1996)
J. Biochem. (Tokyo)
120,
736-744 |
| 19. |
Inouye, S.
(1994)
DEBS Lett.
347,
163-168 |
| 20. |
Park, H. J.,
Reiser, C. O.,
Kondruweit, H.,
Erdmann, R. D.,
and Schmid, M.
(1992)
Eur. J. Biochem.
205,
881-885[Medline]
[Order article via Infotrieve] |
| 21. |
Park, H. J.,
Kreutzer, R.,
Reiser, C. O.,
and Sprinzl, M.
(1993)
Eur. J. Biochem.
211,
909[Medline]
[Order article via Infotrieve] |
| 22. |
Zenno, S.,
Koike, H.,
Kumar, A. N.,
Jayaraman, R.,
Tanokura, M.,
and Saigo, K.
(1996)
J. Bacteriol.
178,
4508-4514 |
| 23. |
Lei, B.,
Liu, M.,
Huang, S.,
and Tu, S.-C.
(1994)
J. Bacteriol.
176,
3552-3558 |
| 24. |
Hecht, H. J.,
Erdmann, H.,
Park, H.-J.,
Sprinzl, M.,
and Schmid, R. D.
(1995)
Nat. Struct. Biol.
2,
1109-1114[CrossRef][Medline]
[Order article via Infotrieve] |
| 25. |
Tanner, J. J.,
Lei, B., Tu, S.-C.,
and Krause, K. L.
(1996)
Biochemistry
35,
13531-13539[CrossRef][Medline]
[Order article via Infotrieve] |
| 26. |
Koike, H.,
Sasaki, H.,
Kobori, T.,
Zenno, S.,
Saigo, K.,
Murphy, M. E.,
Adman, E. T.,
and Tanokura, M.
(1998)
J. Mol. Biol.
280,
259-273[CrossRef][Medline]
[Order article via Infotrieve] |
| 27. |
Parkinson, G. P.,
Skelly, J. V.,
and Neidle, S.
(2000)
J. Med. Chem.
43,
3624-3631[CrossRef][Medline]
[Order article via Infotrieve] |
| 28. |
Kobori, T.,
Sasaki, H.,
Lee, W. C.,
Zenno, S.,
Saigo, K.,
Murphy, M. E.,
and Tanokura, M.
(2001)
J. Biol. Chem.
276,
2816-2823 |
| 29. |
Lovering, A. L.,
Hyde, E. I.,
Searle, P. F.,
and White, S. A.
(2001)
J. Mol. Biol.
309,
203-213[CrossRef][Medline]
[Order article via Infotrieve] |
| 30. |
Koder, R. L.,
and Miller, A.-F.
(1998)
Protein Expr. Purif.
13,
53-60[CrossRef][Medline]
[Order article via Infotrieve] |
| 31. |
Rodgers, D. W.
(1997)
Methods Enzymol.
276,
183-203 |
| 32. |
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326 |
| 33. |
CCP4.
(1994)
Acta Crystallogr. Sect. D Biol. Crystallogr.
50,
760-763[CrossRef][Medline]
[Order article via Infotrieve] |
| 34. |
Brünger, A. T.,
Adams, P. D.,
Clore, G. M.,
Delano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J. N.,
Pannu, N. S.,
Reed, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve] |
| 35. |
Kleywegt, G. J.,
and Jones, T. A.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
1119-1131[CrossRef][Medline]
[Order article via Infotrieve] |
| 36. |
Dixon, D. A.,
Lindner, D. L.,
Branchaud, B.,
and Lipscomb, W. N.
(1979)
Biochemistry
18,
5770-5775[CrossRef][Medline]
[Order article via Infotrieve] |
| 37. |
Jones, T. A.,
Zou, J. Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. A
47,
110-119 |
| 38. |
Michael, N. P.,
Brehm, J. K.,
Anlezark, G. M.,
and Minton, N. P.
(1994)
FEMS Microbiol. Lett.
124,
195-202[CrossRef][Medline]
[Order article via Infotrieve] |
| 39. |
Watanabe, M.,
Ishidate, M., Jr.,
and Nohmi, T.
(1990)
Nucleic Acids Res.
18,
1059 |
| 40. |
Fraaije, M. W.,
and Mattevi, A.
(2000)
Trends Biochem. Sci.
25,
126-132[CrossRef][Medline]
[Order article via Infotrieve] |
| 41. |
Ghisla, S.,
and Massey, V.
(1989)
Eur. J. Biochem.
181,
1-17[Medline]
[Order article via Infotrieve] |
| 42. |
Breinlinger, E. C.,
Keenan, C. J.,
and Rotello, V. M.
(1998)
J. Am. Chem. Soc.
120,
8606-8609[CrossRef] |
| 43. |
Truss, B. L.,
and Fritchie, C. J. J.
(1969)
Acta Crystallogr. Sect. B Struct. Sci.
25,
1911-1918[CrossRef] |
| 44. |
Norrestram, R.,
and Stensland, B.
(1972)
Acta Crystallogr. Sect. B Struct. Sci.
28,
440-447[CrossRef] |
| 45. |
Kuo, M. C.,
Dunn, B. R.,
and Fritchie, C. J. J.
(1974)
Acta Crystallogr. Sect. B Struct. Sci.
30,
1766-1771[CrossRef] |
| 46. |
Porter, D. J. T.,
and Voet, D.
(1978)
Acta Crystallogr. Sect. B Struct. Sci.
34,
598-610[CrossRef] |
| 47. |
Fritchie, C. J. J.,
and Johnston, R. M.
(1975)
Acta Crystallogr. Sect. B Struct. Sci.
31,
454-461[CrossRef] |
| 48. |
Moonen, C. T. W.,
Vervoort, J.,
and Müller, F.
(1984)
Biochemistry
23,
4859-4867[CrossRef][Medline]
[Order article via Infotrieve] |
| 49. | Wouters, J., Moureau, F., Perpète, P., Norberg, B., Evard, G., and Durant, F. (1994) J. Chem. Crystallogr. 24, 607-614[CrossRef] |
| 50. | Hall, L. H., Orchard, B. J., and Tripathy, S. K. (1987) Int. J. Quant. Chem. 31, 195-216[CrossRef] |
| 51. |
Platenkamp, R. J.,
Palmer, M. H.,
and Visser, A. J. W. G.
(1987)
Eur. Biophys. J.
14,
393-402 |
| 52. | Meyer, M., Hartwig, H., and Schomburg, D. (1996) J. Mol. Struct. (Theochem) 364, 139-149[CrossRef] |
| 53. |
Zheng, Y.-J.,
and Ornstein, R. L.
(1996)
J. Am. Chem. Soc.
118,
9402-9408[CrossRef] |
| 54. |
Lennon, B. W.,
Williams, C. H.,
and Ludwig, M. L.
(1999)
Protein Sci.
8,
2366-2379[Abstract] |
| 55. |
Müller, Y. A.,
Schumacher, G.,
Rudolph, R.,
and Schulz, G. E.
(1994)
J. Mol. Biol.
237,
315-335[CrossRef][Medline]
[Order article via Infotrieve] |
| 56. |
McGaughey, G. B.,
Gagné, M.,
and Rappé, A. K.
(1998)
J. Biol. Chem.
273,
15458-15463 |
| 57. |
Pai, E.,
Karplus, P. A.,
and Schulz, G. E.
(1988)
Biochemistry
27,
4465-4474[CrossRef][Medline]
[Order article via Infotrieve] |
| 58. |
Karplus, P. A.,
and Schulz, G. E.
(1989)
J. Mol. Biol.
210,
163-180[CrossRef][Medline]
[Order article via Infotrieve] |
| 59. |
Li, R.,
Bianchet, M. A.,
Talalay, P.,
and Amzel, L. M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8846-8850 |
| 60. |
Zenno, S.,
Koike, H.,
Tanokura, M.,
and Saigo, K.
(1996)
J. Bacteriol.
178,
4731-4733 |
| 61. |
Isaya, G.,
Kalousek, F.,
Fenton, W. A.,
and Rosenberg, L. E.
(1991)
J. Cell Biol.
113,
65-76 |
| 62. |
Moonen, C. T. W.,
Vervoort, J.,
and Müller, F.
(1984)
Biochemistry
23,
4868-4872[CrossRef][Medline]
[Order article via Infotrieve] |
| 63. | Nakai, S., Yoneda, F., and Yamabe, T. (1999) Theor. Chem. Acc. 103, 109-116[CrossRef] |
| 64. |
Cavelier, G.,
and Amzel, L. M.
(2001)
Proteins
43,
420-432[CrossRef][Medline]
[Order article via Infotrieve] |
| 65. |
Massey, V.,
and Hemmerich, P.
(1980)
Biochem. Soc. Trans.
8,
246-257[Medline]
[Order article via Infotrieve] |
| 66. |
Hasford, J. J.,
Kemnitzer, W.,
and Rizzo, C. J.
(1997)
J. Org. Chem.
62,
5244-5245[CrossRef] |
| 67. |
Trickey, P.,
Basran, J.,
Lian, L.-Y.,
Chen, Z.-W.,
Barton, J. D.,
Sutcliffe, M. J.,
Scrutton, N. S.,
and Matthews, F. S.
(2000)
Biochemistry
39,
7678-7688[CrossRef][Medline]
[Order article via Infotrieve] |
| 68. |
Massey, V.,
Müller, F.,
Feldberg, R.,
Schuman, M.,
Sullivan, P. A.,
Howell, L. G.,
Mayhew, S. G.,
Matthews, R. G.,
and Foust, G. P.
(1969)
J. Biol. Chem.
244,
3999-4006 |
| 69. |
Tedeschi, G.,
Chen, S.,
and Massey, V.
(1995)
J. Biol. Chem.
270,
1198-1204 |
| 70. | Prochaska, K. J., and Talalay, P. (1991) in Oxidative Stress: Oxidants and Antioxidants (Sies, H., ed) , pp. 195-211, Academic Press, Ltd., New York |
| 71. |
Liochev, S. I.,
Hausladen, A.,
and Fridovich, I.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3537-3539 |
| 72. |
Ludwig, M. L.,
Pattridge, K. A.,
Metzger, A. L.,
Dixon, M. M.,
Eren, M.,
Feng, Y.,
and Swenson, R.
(1997)
Biochemistry
36,
1259-1280[CrossRef][Medline]
[Order article via Infotrieve] |
| 73. |
Vazquez, S. A.,
Andresw, J. S.,
Murray, C. W.,
Amos, R. D.,
and Handy, N. C.
(1992)
J. Chem. Soc. Perkin Trans. 2
6,
889-895[CrossRef] |
| 74. |
Fox, K. M.,
and Karplus, P. A.
(1994)
Structure
2,
1089-1105[Medline]
[Order article via Infotrieve] |
| 75. |
Stewart, R. C.,
and Massey, V.
(1985)
J. Biol. Chem.
260,
13639-13647 |
| 76. |
Murthy, Y. V. S. N.,
and Massey, V.
(1996)
J. Biol. Chem.
271,
19915-19921 |
| 77. | Müller, F. (1991) in Chemistry and Biochemistry of Flavoenzymes (Müller, F., ed), Vol. 1 , pp. 2-72, CRC Press, Boca Raton |
| 78. |
Carson, M.
(1987)
J. Mol. Graphics
5,
103-106 |
| 79. |
Guex, N.,
and Peitsch, M. C.
(1997)
Electrophoresis
18,
2714-2723[CrossRef][Medline]
[Order article via Infotrieve] |
| 80. | Bryant, C. P. (1990) A Biochemical and Biophysical Investigation of Enterobacter cloacae NitroreductasePh.D. thesis , University of California at San Diego, San Diego, CA |
| 81. | Koder, R. L. (1999) Purification, Cloning, and Characterization of an Oxygen-insensitive NAD(P)H Nitroreductase from Enterobacter cloacae Strain 96-3Ph.D. thesis , The Johns Hopkins University, Baltimore, MD |
This article has been cited by other articles: